Aryl Hydrocarbon Receptor Antibodies

Santa Cruz Biotechnology delivers a wide array of Aryl Hydrocarbon Receptor monoclonal antibodies for research focused on understanding the aryl hydrocarbon receptor (AhR) in various biological processes. Aryl Hydrocarbon Receptor monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The aryl hydrocarbon receptor is a ligand-activated transcription factor that plays a crucial role in mediating the effects of environmental toxins and regulating immune responses. AhR is involved in the metabolism of xenobiotics and has been implicated in various physiological and pathological processes, including cancer, inflammation, and developmental biology. Understanding the function of the aryl hydrocarbon receptor is essential for elucidating its impact on health and disease. Researchers can explore AhR signaling pathways through detailed molecular analysis and cellular localization studies. Advanced imaging techniques combined with Aryl Hydrocarbon Receptor monoclonal antibodies enable visualization of protein distribution and interactions within cellular compartments. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of AhR biology and its implications in human health.